ArticleCureus2025
Assessment of Serum Ferritin Levels in Female Patients With Telogen Effluvium.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Telogen effluvium (TE) is a non-scarring form of diffuse hair loss characterized by premature transition of hair follicles into the telogen phase, resulting in excessive shedding. Iron deficiency, reflected by low serum ferritin levels, is considered a potential contributor to TE in women. Aim The aim of this study was to evaluate serum ferritin levels in female patients with TE and compare them with controls. Methods A cross-sectional comparative study was conducted involving 100 female participants - 50 diagnosed with TE and 50 healthy controls. Serum ferritin and hemoglobin levels were measured in both groups. Demographic, lifestyle, hormonal, and clinical variables were recorded to account for potential confounders. Data analysis was performed using SPSS version 20.0 (IBM Inc., Armonk, New York), employing independent t-tests for continuous variables and Chi-squared tests for categorical variables. Results Mean serum ferritin levels were significantly lower in TE cases (24.30 ± 11.13 ng/mL) compared to controls (44.78 ± 19.89 ng/mL; p<0.001). Reduced ferritin levels (<15 ng/mL) were observed in 14 (28%) TE cases, while none of the controls exhibited such deficiencies. Additionally, 31 (62%) TE cases demonstrated significant hair shedding, with a positive hair pull test in the same proportion. Conclusion Low serum ferritin levels are significantly associated with telogen effluvium in women. Serum ferritin may serve as a useful biomarker for identifying iron deficiency in patients presenting with diffuse hair loss.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.